What the Tepezza TV commercial - Jeanne is about.
Tepezza is a prescription medication used for the treatment of thyroid eye disease. The Tepezza TV Spot titled 'Jeanne' features a woman named Jeanne who shares her story of battling thyroid eye disease.
The commercial starts with Jeanne explaining how thyroid eye disease affects her day-to-day life. She talks about how the condition makes her eyes bulge out of their sockets, causes eye pain and dryness, and makes it difficult for her to perform simple tasks.
As the Tepezza TV spot continues, Jeanne explains how this prescription medication has helped improve her condition. She talks about how it has made her feel like herself again and how grateful she is for Tepezza.
Throughout the commercial, visuals of Jeanne's eyes before and after treatment are shown, highlighting the positive impact that Tepezza has had on her appearance and her quality of life.
The spot ends with Jeanne encouraging others who are struggling with thyroid eye disease to talk to their healthcare provider about Tepezza and how it could potentially help them. The message behind this Tepezza TV Spot is to raise awareness about thyroid eye disease and provide information about a prescription medication that can help those with the condition.
Tepezza TV commercial - Jeanne produced for
Tepezza
was first shown on television on May 3, 2021.
Frequently Asked Questions about tepezza tv spot, 'jeanne'
TEPEZZA reduces eye bulging and double vision. It also improves the signs and symptoms of Thyroid Eye Disease (TED), including eye pain, redness, and swelling. TEPEZZA is a prescription medicine used to treat TED. You should discuss the risks and benefits of using TEPEZZA with your doctor.
Tepezza™ was developed in part by former The Lundquist Institute investigator Dr. Terry Smith, and the institute licensed the treatment to River Vision and Horizon Therapeutics to treat Thyroid Eye Disease.
Since Tepezza is a biologic drug, it can't have a generic version. This is because biologics are made from living cells and can't be replicated exactly. Instead, it's possible for biologic drugs to have biosimilar versions. Biosimilars are just as safe and effective as the original biologic but often cost less.
Generic Name: teprotumumab-trbw
This medication is used to treat thyroid eye disease, also known as Graves' eye disease. Teprotumumab belongs to a class of drugs known as monoclonal antibodies.
Intravenous Powder For Injection
| Quantity | Per unit | Price |
|---|
| 1 | $16,301.09 | $16,301.09 |
TED is primarily associated with an over-active thyroid gland due to Graves' disease, although it can rarely occur in patients with an under-active or normally functioning thyroid gland. About a quarter of patients with Graves' disease develop TED before, during or after the diagnosis of a thyroid disorder.
Johnson & Johnson initially tapped Catalent in April to reserve fill-finish capacity at its Bloomington, Indiana, plant - where Tepezza is made - before signing on the CDMO's Anagni, Italy facility for additional production work in July.
Tepezza is now Horizon's second marketed biologic alongside gout med Krystexxa, which raked in more than $300 million in 2019. With both drugs estimated to hit blockbuster territory, Walbert said the company would be looking for acquisition targets to build its pipeline in nephrology, rheumatology and endocrinology.
Intravenous Powder For Injection
| Quantity | Per unit | Price |
|---|
| 1 | $16,301.09 | $16,301.09 |
Treatment with TEPEZZA is 8 infusions. Each infusion is given 1 time every 3 weeks. That means the full course of treatment with TEPEZZA lasts about 5 months. Your first and second infusions of TEPEZZA will last about 90 minutes each.
TEPEZZA is a prescription medicine used to treat Thyroid Eye Disease (TED), no matter if you've had TED for months or years.
Mild thyroid eye disease may resolve on its own, while more serious cases of TED may require a combination of therapies. The outlook for people who are over 50 years old when diagnosed may not be as positive.
